Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT03761394
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT03761394
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03761394. Randomized; single masking; primary purpose diagnostic. Start 2019-09-03 (actual); primary completion 2021-09-20 (actual). Results posted on 2023-11-18.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke
- Condition
- Stroke
- Condition
- Atrial Fibrillation
- Intervention (Device)
- Testing Devices
- Intervention (Device)
- Cardea Solo by Cardiac Insight
- Intervention (Device)
- Kardia Mobile by AliveCor
- Lead sponsor
- University of Massachusetts, Worcester
- Collaborator
- University of Connecticut
- Collaborator
- Northeastern University
- Collaborator
- Brigham and Women's Hospital
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct03761394- Content hash
67d412bdfa4383045db385bd62f0f729e379122ef4e13095fdfb4a6d3040def0